RU2003102633A - WAYS OF SYNTHESIS OF APLIDINE AND NEW ANTITUMOR DERIVATIVES, WAYS OF THEIR INDUSTRIAL OBTAINING AND APPLICATION - Google Patents
WAYS OF SYNTHESIS OF APLIDINE AND NEW ANTITUMOR DERIVATIVES, WAYS OF THEIR INDUSTRIAL OBTAINING AND APPLICATIONInfo
- Publication number
- RU2003102633A RU2003102633A RU2003102633/04A RU2003102633A RU2003102633A RU 2003102633 A RU2003102633 A RU 2003102633A RU 2003102633/04 A RU2003102633/04 A RU 2003102633/04A RU 2003102633 A RU2003102633 A RU 2003102633A RU 2003102633 A RU2003102633 A RU 2003102633A
- Authority
- RU
- Russia
- Prior art keywords
- group
- aplidine
- substituted
- hiv
- compound according
- Prior art date
Links
- 108010049948 plitidepsin Proteins 0.000 title claims 25
- UUSZLLQJYRSZIS-LXNNNBEUSA-N Aplidine Chemical compound CN([C@H](CC(C)C)C(=O)N[C@@H]1C(=O)N[C@@H]([C@H](CC(=O)O[C@H](C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(OC)=CC=2)C(=O)O[C@@H]1C)C(C)C)O)[C@@H](C)CC)C(=O)[C@@H]1CCCN1C(=O)C(C)=O UUSZLLQJYRSZIS-LXNNNBEUSA-N 0.000 title claims 24
- 230000000259 anti-tumor Effects 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000002194 synthesizing Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 34
- XQZOGOCTPKFYKC-VSZULPIASA-N (2R)-N-[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]-4-methyl-2-(m Chemical compound C([C@H]1C(=O)O[C@H](C)[C@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H]([C@H](CC(=O)O[C@H](C(=O)[C@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N1C)C(C)C)O)[C@@H](C)CC)C1=CC=C(OC)C=C1 XQZOGOCTPKFYKC-VSZULPIASA-N 0.000 claims 13
- 125000003118 aryl group Chemical group 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 10
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 9
- 125000003710 aryl alkyl group Chemical group 0.000 claims 9
- 125000000623 heterocyclic group Chemical group 0.000 claims 9
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N Coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims 8
- 125000000962 organic group Chemical group 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 7
- 125000003277 amino group Chemical group 0.000 claims 7
- 125000003003 spiro group Chemical group 0.000 claims 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 6
- 125000002252 acyl group Chemical group 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 6
- 239000004471 Glycine Substances 0.000 claims 5
- -1 N-substituted proline Chemical class 0.000 claims 5
- 229960000956 coumarin Drugs 0.000 claims 4
- 235000001671 coumarin Nutrition 0.000 claims 4
- 150000002333 glycines Chemical class 0.000 claims 4
- 239000004474 valine Substances 0.000 claims 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 3
- 150000003147 proline derivatives Chemical class 0.000 claims 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims 3
- MHJJUOJOAJLYBS-ZBRNBAAYSA-N (2S)-2-aminopropanoic acid;(2S)-pyrrolidine-2-carboxylic acid Chemical class C[C@H](N)C(O)=O.OC(=O)[C@@H]1CCCN1 MHJJUOJOAJLYBS-ZBRNBAAYSA-N 0.000 claims 2
- SZXBQTSZISFIAO-ZETCQYMHSA-N (2S)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C SZXBQTSZISFIAO-ZETCQYMHSA-N 0.000 claims 2
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid zwitterion Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 claims 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N Nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- 239000011616 biotin Chemical group 0.000 claims 2
- 229960002685 biotin Drugs 0.000 claims 2
- 235000020958 biotin Nutrition 0.000 claims 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 150000003679 valine derivatives Chemical class 0.000 claims 2
- WKQUFVTUGGLNNO-ZETCQYMHSA-N (2S)-1-(2-methylpropanoyl)pyrrolidine-2-carboxylic acid Chemical compound CC(C)C(=O)N1CCC[C@H]1C(O)=O WKQUFVTUGGLNNO-ZETCQYMHSA-N 0.000 claims 1
- ZQEBQGAAWMOMAI-ZETCQYMHSA-N (2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical class CC(C)(C)OC(=O)N1CCC[C@H]1C(O)=O ZQEBQGAAWMOMAI-ZETCQYMHSA-N 0.000 claims 1
- JFSJTTPJLNOARZ-RITPCOANSA-N (2S)-1-[(2R)-2-hydroxypropanoyl]pyrrolidine-2-carboxylic acid Chemical group C[C@@H](O)C(=O)N1CCC[C@H]1C(O)=O JFSJTTPJLNOARZ-RITPCOANSA-N 0.000 claims 1
- MNBMMCWNGWCVPX-ZETCQYMHSA-N (2S)-3-methyl-2-(2-methylpropanoylamino)butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)C(C)C MNBMMCWNGWCVPX-ZETCQYMHSA-N 0.000 claims 1
- FQNKNBPKCHOOOO-VDQHJUMDSA-N OC(=O)[C@@H]1CCCN1.OC(=O)[C@H](C)NC(=O)OC(C)(C)C Chemical compound OC(=O)[C@@H]1CCCN1.OC(=O)[C@H](C)NC(=O)OC(C)(C)C FQNKNBPKCHOOOO-VDQHJUMDSA-N 0.000 claims 1
- FULZLIGZKMKICU-UHFFFAOYSA-N Phenylthiocarbamide Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 claims 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- GMEGXJPUFRVCPX-UHFFFAOYSA-N butylthiourea Chemical compound CCCCNC(N)=S GMEGXJPUFRVCPX-UHFFFAOYSA-N 0.000 claims 1
- CNWSQCLBDWYLAN-UHFFFAOYSA-N butylurea Chemical compound CCCCNC(N)=O CNWSQCLBDWYLAN-UHFFFAOYSA-N 0.000 claims 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- LUBJCRLGQSPQNN-UHFFFAOYSA-N phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Claims (34)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0016148.9 | 2000-06-30 | ||
GB0103750.6 | 2001-02-15 | ||
GB0103750A GB0103750D0 (en) | 2001-02-15 | 2001-02-15 | Synthetic methods for aplidine and new antitumoral derivatives methods of making and using them |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2003102633A true RU2003102633A (en) | 2004-08-10 |
RU2299887C2 RU2299887C2 (en) | 2007-05-27 |
Family
ID=9908814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003102633/04A RU2299887C2 (en) | 2001-02-15 | 2001-07-02 | Methods for synthesis of aplidine and novel anti-tumor derivatives, methods for their industrial preparing and using |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0103750D0 (en) |
RU (1) | RU2299887C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2521193C2 (en) * | 2012-10-17 | 2014-06-27 | Александр Борисович Полетаев | Method for preparing anticancer agent for treating solid tumours |
-
2001
- 2001-02-15 GB GB0103750A patent/GB0103750D0/en not_active Ceased
- 2001-07-02 RU RU2003102633/04A patent/RU2299887C2/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004502702A5 (en) | ||
CA2414609A1 (en) | Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them | |
AU2007262748B2 (en) | Macrocyclic compounds as antiviral agents | |
AU2006276189B9 (en) | HCV NS3 protease inhibitors | |
ES2326707T3 (en) | INHIBITING TRIPEPTIDES OF HEPATITIS C. | |
KR910011891A (en) | Peptide compound, preparation method thereof and pharmaceutical composition containing same | |
YU70701A (en) | Macrocyclic peptides active against hepatitis c virus | |
CA2606195A1 (en) | Hcv ns3 protease inhibitors | |
IL103844A (en) | Rebeccamycin analogs, their preparation and pharmaceutical compositions containing them | |
WO1999064442A1 (en) | Peptide inhibitors of hepatitis c virus ns3 protease | |
ES2248485T3 (en) | PROCEDURE FOR QUICK SYNTHESIS OF PEPTIDES IN SOLUTION. | |
BODANSZKY | Active esters in peptide synthesis | |
Aggen et al. | The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity | |
ES2354488T3 (en) | ALFA-N-METHYLATION OF AMINO ACIDS. | |
ES2301554T3 (en) | CYCLING UREAS COMPOUNDS AND THEIR PREPARATION PROCEDURE. | |
RU2003102633A (en) | WAYS OF SYNTHESIS OF APLIDINE AND NEW ANTITUMOR DERIVATIVES, WAYS OF THEIR INDUSTRIAL OBTAINING AND APPLICATION | |
ES2211628T3 (en) | BASIC MONOCICLIC COMPOUNDS THAT PRESENT NK2 ANTAGONIST ACTIVITY, PROCEDURES FOR THEIR PREPARATION, AND FORMULATIONS THAT CONTAIN THEM. | |
Hojo et al. | Solid-phase peptide synthesis in water. Part 3: A water-soluble N-protecting group, 2-[phenyl (methyl) sulfonio] ethoxycarbonyl tetrafluoroborate, and its application to solid phase peptide synthesis in water | |
Freeman et al. | Total synthesis and assignment of stereochemistry of raocyclamide cyclopeptides from cyanobacterium Oscillatoria raoi | |
Shao et al. | Synthesis and structure revision of symplocin A | |
US6787612B1 (en) | Resin derivatization method and uses thereof | |
McKeever et al. | Total synthesis of mollamide, a reverse prenyl substituted cytotoxic cyclic peptide from Didemnum molle | |
JP2006505555A5 (en) | ||
Bock et al. | Differentially protected. alpha.-aminoglycine | |
EP1961759A1 (en) | Integrin targeted cyclopeptide ligands, their preparation and use |